Description
Recombinant Human Annexin A8/ANXA8 Protein | PKSH032078 | Gentaur US, UK & Europe Disrtribition
Synonyms: Annexin A8; Annexin VIII; Annexin-8; Vascular Anticoagulant-Beta; VAC-Beta; ANXA8; ANX8
Active Protein: N/A
Activity: Recombinant Human Annexin A8 is produced by our E.coli expression system and the target gene encoding Met1-Pro327 is expressed.
Protein Construction: Recombinant Human Annexin A8 is produced by our E.coli expression system and the target gene encoding Met1-Pro327 is expressed.
Fusion Tag:
Species: Human
Expressed Host: E.coli
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Purity: > 95 % as determined by reducing SDS-PAGE.
Endotoxin: < 1.0 EU per µg as determined by the LAL method.
Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Molecular Mass: 36.9 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.
Reconstitution: Please refer to the printed manual for detailed information.
Background: Annexin A8 (ANXA8) belongs to a family of calcium-dependent membrane and phospholipid binding proteins. Annexin A8 contains 4 annexin repeats separated by linking sequences of variable lengths. A pair of annexin repeats may form one binding site for calcium and phospholipid. ANXA8 is preferentially expressed in acute promyelocytic leukemia (APL) cells, which suggests its participation in hematopoietic cell differentiation. In addition, ANXA8 is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade.
Research Area: Signal Transduction, Cardiovascular,
